共 50 条
- [3] The use of everolimus in the fourth line of treatment in patients with advanced kidney cancer ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C41 - C43
- [4] The use of everolimus in the third line of treatment in patients with advanced kidney cancer ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C38 - C40
- [5] Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 91 - 101
- [6] Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 799 - 806
- [7] Lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: an initial Russian experience ONKOUROLOGIYA, 2018, 14 (01): : 76 - 86
- [10] Recommendations for the treatment of patients with advanced or metastatic renal cell cancer with the combination of lenvatinib and everolimus ONKOUROLOGIYA, 2020, 16 (04): : 61 - 81